0 CHECKOUT

Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

  • ID: 2858723
  • May 2014
  • Region: Global
  • 111 pages
  • GlobalData
1 of 3

Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

Summary

Our clinical trial report, “Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Squamous Cell Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Squamous Cell Carcinoma
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Squamous Cell Carcinoma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Squamous Cell Carcinoma
Nov 05, 2013: ImmunoGen Initiates Phase I Testing of Its EGFR-Targeting ADC, IMGN289
Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer
Jul 02, 2013: VentiRx Pharmaceuticals Initiates the ACTIVE8 Phase 2 Clinical Trial Evaluating VTX-2337 in Combination with Cetuximab and Chemotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer
Feb 08, 2013: Oncolytics Biotech Announces Additional Positive Reolysin Clinical Trial Data From Phase II Study In Squamous Cell Carcinoma Of Lung
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sanofi
Clinical Trial Overview of Sanofi
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Novartis AG
Clinical Trial Overview of Novartis AG
E. Merck KG
Clinical Trial Overview of E. Merck KG
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Gynecologic Oncology Group
Clinical Trial Overview of Gynecologic Oncology Group
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Radiation Therapy Oncology Group
Clinical Trial Overview of Radiation Therapy Oncology Group
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Stanford University
Clinical Trial Overview of Stanford University
FUDAN University
Clinical Trial Overview of FUDAN University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014-
Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014-
Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014-
Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014-
Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014-

List of Figures
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014-
Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014-
Squamous Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014-
Proportion of Squamous Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014-
Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014-
Squamous Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014-
Squamous Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014-
Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014-
GlobalData Methodology

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pharmaceutical Product Development
  • Quintiles Transnational
  • Covance Inc.
  • Charles River
  • Accovion
  • INC Research